Navigation Links
Aware, Inc. Reports First Quarter 2012 Financial Results
Date:4/27/2012

orted to us by one of our DSL chip licensees.

Spending declined from $5.8 million in the first quarter of 2011 to $4.7 million this quarter. The $1.1 million spending decrease was primarily the result of: i) lower hardware cost of goods sold on lower hardware sales; ii) lower expenses in our DSL service assurance engineering organization; and iii) lower CEO related expenses because our former CEO, who resigned on April 1, 2011, was replaced with existing members of senior management.

We had 74 full time employees at March 31, 2012, which was down from 77 heads at the end of last quarter.

Rick Moberg, Aware's co-chief executive officer and chief financial officer, said, "This was the third consecutive quarter that net income was approximately $1.0 million or more.  Net income of $1.1 million this quarter was driven by a transition towards Aware becoming primarily a software company as well as lower expenses.  Cash and investments grew by $1.7 million to $49.0 million." 

As we previously disclosed, our board of directors has been considering strategic options with respect to the monetization of a significant portion of our patent portfolio.  On April 27, 2012, we filed a Form 8-K with the Securities and Exchange Commission that reports we have entered into an agreement for a significant sale of patents.  The sale is subject to customary closing conditions and any required regulatory approvals. We expect to be able to use our deferred tax assets to substantially or completely offset taxable income attributable to this transaction.  We intend to continue to pursue patent monetization alternatives for certain other patents remaining in our patent portfolio. We are unable to predict the size or the timing of any future potential transactions involving such patents or whether such transactions will be completed.

We believe that the sale of these patents will have no material impact on our biometrics and imag
'/>"/>

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Aware, Inc. Reports Fourth Quarter and 2011 Financial Results
2. Aware, Inc. Reports Third Quarter 2011 Financial Results
3. Aware, Inc. Reports Second Quarter 2011 Financial Results
4. Aware, Inc. Reports Second Quarter 2011 Financial Results
5. Aware, Inc. Announces Resignation of Chief Executive Officer
6. Aware, Inc. Reports First Quarter 2011 Financial Results
7. Aware, Inc. Announces Resignation of Chief Executive Officer
8. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
9. Aware, Inc. Announces Q4 and FY2010 Earnings Conference Call
10. Aware, Inc. Reports Third Quarter 2010 Financial Results
11. Aware, Inc. Announces Q310 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... Ahram Biosystems, Inc., a leading innovator of new life ... PCR system, an innovative portable PCR device that delivers ... format. The palm-sized, battery-powered Palm PCR thermocycler ... to extend the range of applications of this well-established ...
... years with Chip Supply, Inc., President & CEO Edward ... served in various capacities through the years, becoming president ... grew into the largest independent die distributor in the ... high reliability interconnect solutions, serving the military, aerospace, medical, ...
... Nitrogen is essential for plant growth. Despite the abundance ... must rely on a series of chemical reactions to ... forms. Plants have achieved this goal primarily by evolving ... nitrogen, plants, and the environment are the focus of ...
Cached Biology News:Ahram Biosystems Announces Launch of the Palm PCR(TM) Portable PCR System 2Book looks at interrelationships among nitrogen, plants and the environment 2
(Date:7/30/2015)... July 30, 2015 AACC welcomed thousands ... 2015 AACC Annual Meeting & Clinical Lab Expo ... 26–30. The meeting showcased revolutionary advancements in clinical ... of healthcare providers to diagnose patients quickly and ... treatment. As of Wednesday, July ...
(Date:7/30/2015)... ... , ... The 2015 Market Research Report on the Global Propanol Industry ... Propanol market with a focus on the Chinese situation. Major companies included in the ... Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... group of chief information officers for their number-one issue, ... , ,Today, the consensus issue is compliance, particularly with ... passage of the Sarbanes-Oxley Act of 2002, or SOX, ... was passed largely in reaction to the corporate scandals ...
... has installed its first volume computed tomography scanner, which takes ... cardiologist. , ,Round Rock Cardiology in Texas will use GE's ... GE said the scans take less time than five heartbeats. ... a three-dimensional view. , ,The scanner entered general clinical use ...
... a great job of tracking U.S. biotech financing in all its ... other biotech companies and Big Pharma). From its recent analysis, it ... in almost all the financing categories. Lets take a look: , ... $25.3 billion flowing into the biotech sector from a variety of ...
Cached Biology Technology:With Sarbanes-Oxley, compliance takes center stage for CIOs 2With Sarbanes-Oxley, compliance takes center stage for CIOs 32004 a banner year for biotech financing 2
...
Rubeola (Measles) Antigen Preservative: No Preservatives...
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Homo sapiens jumping translocation breakpoint...
Biology Products: